rTMS Modulates Static and Dynamic Brain Functional Networks in Children with Autism Spectrum Disorder: An EEG Microstate Study.
Quick Take: rTMS shows a modulatory effect on brain functional networks in children with ASD, suggesting a potential therapeutic avenue requiring further validation.
💡 Clinical Impact
- Mechanistic Why: This data necessitates understanding how rTMS impacts the dynamic and static functional connectivity within the autistic brain, particularly targeting network abnormalities implicated in social communication deficits and repetitive behaviors.
- Clinical/Systemic Benefit: A validated rTMS protocol could offer a non-invasive, targeted intervention for ASD, potentially improving core symptom severity and reducing reliance on pharmacological or intensive behavioral therapies alone.
📊 Evidence Breakdown Grade: 🟡 6/10 (Pilot/Exploratory)
Analysis: This EEG microstate study provides an early signal of rTMS's neuromodulatory effects in pediatric ASD. While demonstrating a statistically significant change in specific network metrics, the relatively small sample size and lack of a sham-controlled design limit definitive conclusions regarding efficacy and generalizability. The variance in rTMS parameters (frequency, intensity, duration) across studies also introduces considerable heterogeneity.
Note: The long-term durability of these network changes and their correlation with meaningful clinical improvements are yet to be established.
🩺 Practice Recommendation [Investigational Only]: Do not initiate rTMS for ASD treatment outside of a registered clinical trial. Focus on established therapies. Discuss rTMS as a future possibility if further robust data emerges.